Pharmacology of Desloratadine
- 1 January 2002
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 22 (Supplement) , 1-11
- https://doi.org/10.2165/00044011-200222002-00001
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Desloratadine in the treatment of chronic idiopathic urticariaAllergy, 2001
- Efficacy and Tolerability of Once-Daily 5mg Desloratadine, an H1-Receptor Antagonist, in Patients with Seasonal Allergic RhinitisClinical Drug Investigation, 2001
- Drug–Grapefruit Juice InteractionsMayo Clinic Proceedings, 2000
- Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) FamilyBiochemical and Biophysical Research Communications, 2000
- Second-generation antihistamines: The risk of ventricular arrhythmiasClinical Therapeutics, 1999
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- LoratadineDrugs, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- LoratadineDrugs, 1989
- Pharmacokinetics and Dose Proportionality of LoratadineThe Journal of Clinical Pharmacology, 1987